Sandra J. Horning

32.4k total citations · 6 hit papers
228 papers, 19.4k citations indexed

About

Sandra J. Horning is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Sandra J. Horning has authored 228 papers receiving a total of 19.4k indexed citations (citations by other indexed papers that have themselves been cited), including 191 papers in Pathology and Forensic Medicine, 102 papers in Oncology and 57 papers in Genetics. Recurrent topics in Sandra J. Horning's work include Lymphoma Diagnosis and Treatment (190 papers), Chronic Lymphocytic Leukemia Research (57 papers) and Viral-associated cancers and disorders (57 papers). Sandra J. Horning is often cited by papers focused on Lymphoma Diagnosis and Treatment (190 papers), Chronic Lymphocytic Leukemia Research (57 papers) and Viral-associated cancers and disorders (57 papers). Sandra J. Horning collaborates with scholars based in United States, Canada and Germany. Sandra J. Horning's co-authors include Richard T. Hoppe, Saul A. Rosenberg, Richard I. Fisher, Randy D. Gascoyne, Joseph M. Connors, Anton Hagenbeek, Julie M. Vose, Ranjana H. Advani, Thomas M. Habermann and Edie Weller and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Sandra J. Horning

224 papers receiving 18.8k citations

Hit Papers

Revised Response Criteria for Malignan... 1984 2026 1998 2012 2007 1999 2006 2000 1984 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Revised Response Criteria for Malignant Lymphoma
    2007 3.2k citations Bruce D. Cheson, Malik E. Juweid et al. Journal of Clinical Oncology profile →
  2. Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas
    1999 2.8k citations Sandra J. Horning, Richard I. Fisher et al. Journal of Clinical Oncology profile →
  3. Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell Lymphoma
    2006 997 citations Thomas M. Habermann, Edie Weller et al. Journal of Clinical Oncology profile →
  4. Impact of Cancer-Related Fatigue on the Lives of Patients: New Findings From the Fatigue Coalition
    2000 979 citations Sandra J. Horning et al. profile →
  5. The Natural History of Initially Untreated Low-Grade Non-Hodgkin's Lymphomas
    1984 712 citations Sandra J. Horning et al. profile →
  6. Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition.
    1997 625 citations Sandra J. Horning et al. profile →

Peers

Sandra J. Horning
Jamés O. Armitage United States
George P. Canellos United States
Catherine Thiéblemont France
John F. Seymour Australia
Hanneke C. Kluin‐Nelemans Netherlands
Pinuccia Valagussa Italy
Thierry Philip France
Richard Sposto United States
Michael Crump Canada
Mark Krailo United States
Jamés O. Armitage United States
Sandra J. Horning
Citations per year, relative to Sandra J. Horning Sandra J. Horning (= 1×) peers Jamés O. Armitage

Countries citing papers authored by Sandra J. Horning

Since Specialization
Citations

This map shows the geographic impact of Sandra J. Horning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra J. Horning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra J. Horning more than expected).

Fields of papers citing papers by Sandra J. Horning

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra J. Horning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra J. Horning. The network helps show where Sandra J. Horning may publish in the future.

Co-authorship network of co-authors of Sandra J. Horning

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra J. Horning. A scholar is included among the top collaborators of Sandra J. Horning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra J. Horning. Sandra J. Horning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kahl, Brad S., Fangxin Hong, Michael E. Williams, et al.. (2014). Rituximab Extended Schedule or Re-Treatment Trial for Low–Tumor Burden Follicular Lymphoma: Eastern Cooperative Oncology Group Protocol E4402. Journal of Clinical Oncology. 32(28). 3096–3102. 138 indexed citations
2.
Horning, Sandra J., Daniel A. Haber, Wendy Selig, et al.. (2013). Developing Standards for Breakthrough Therapy Designation in Oncology. Clinical Cancer Research. 19(16). 4297–4304. 24 indexed citations
3.
4.
5.
6.
7.
Ganz, Patricia A. & Sandra J. Horning. (2007). Cancer survivorship : today and tomorrow. DIAL (Catholic University of Leuven). 54 indexed citations
8.
Advani, Ranjana H., Steven Horwitz, Andrew D. Zelenetz, & Sandra J. Horning. (2007). Angioimmunoblastic T cell lymphoma: Treatment experience with cyclosporine. Leukemia & lymphoma. 48(3). 521–525. 54 indexed citations
9.
Heidenreich, Paul A., Ingela Schnittger, H. William Strausś, et al.. (2006). Screening for Coronary Artery Disease After Mediastinal Irradiation for Hodgkin's Disease. Journal of Clinical Oncology. 25(1). 43–49. 186 indexed citations
10.
Ganjoo, Kristen N., Caroline An, Michael J. Robertson, et al.. (2006). Rituximab, Bevacizumab and CHOP (RA-CHOP) in untreated diffuse large B-cell lymphoma: Safety, biomarker and pharmacokinetic analysis. Leukemia & lymphoma. 47(6). 998–1005. 83 indexed citations
11.
12.
Beynet, David, et al.. (2004). Clinical and Pathological Features of Posttransplantation Lymphoproliferative Disorders Presenting With Skin Involvement in 4 Patients. Archives of Dermatology. 140(9). 1140–6. 27 indexed citations
13.
Ekstrand, Bradley C. & Sandra J. Horning. (2002). Lymphocyte predominant Hodgkin’s disease. Current Oncology Reports. 4(5). 424–433. 7 indexed citations
14.
Stuart, Monic J., Nelson J. Chao, Sandra J. Horning, et al.. (2001). Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's disease. Biology of Blood and Marrow Transplantation. 7(10). 552–560. 17 indexed citations
15.
Johnston, Laura, Keith Stockerl‐Goldstein, Wendy Hu, et al.. (2000). Toxicity of high-dose sequential chemotherapy and purged autologous hematopoietic cell transplantation precludes its use in refractory/recurrent non-Hodgkin's lymphoma. Biology of Blood and Marrow Transplantation. 6(5). 555–562. 11 indexed citations
16.
Johnston, Laura & Sandra J. Horning. (1999). AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION IN NON-HODGKIN'S LYMPHOMA. Hematology/Oncology Clinics of North America. 13(5). 889–918. 10 indexed citations
17.
Horning, Sandra J.. (1998). Primary refractory Hodgkin’s disease. Annals of Oncology. 9. s97–s101. 17 indexed citations
18.
Horning, Sandra J., et al.. (1994). Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma.. Journal of Clinical Oncology. 12(12). 2552–2558. 68 indexed citations
19.
Advani, Ranjana H., Nelson J. Chao, Sandra J. Horning, et al.. (1992). Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) as an Adjunct to Autologous Hemopoietic Stem Cell Transplantation for Lymphoma. Annals of Internal Medicine. 116(3). 183–189. 105 indexed citations
20.
Horning, Sandra J., Nelson J. Chao, Robert S. Negrin, et al.. (1991). The Stanford experience with high-dose etoposide cytoreductive regimens and autologous bone marrow transplantation in Hodgkin's disease and non-Hodgkin's lymphoma: Preliminary data. Annals of Oncology. 2. 47–50. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jamés O. Armitage Breakdown of academic impact, for papers by George P. Canellos Breakdown of academic impact, for papers by Catherine Thiéblemont Breakdown of academic impact, for papers by John F. Seymour Breakdown of academic impact, for papers by Hanneke C. Kluin‐Nelemans Breakdown of academic impact, for papers by Pinuccia Valagussa Breakdown of academic impact, for papers by Thierry Philip Breakdown of academic impact, for papers by Richard Sposto Breakdown of academic impact, for papers by Michael Crump Breakdown of academic impact, for papers by Mark Krailo
Rankless by CCL
2026